Editorial (Thematic Issue: GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases)

E-ISSN： 1873-4286|21|34|4937-4938

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.34, 2015-10, pp. : 4937-4938

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Immune Modulation)

Current Pharmaceutical Design, Vol. 22, Iss. 41, 2016-12 ,pp. : 6207-6208

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Anti-inflammatory Drugs in the Treatment of Inflammatory Periodontal Diseases)

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Targeting Phosphodiesterases (PDEs) for Treatment of CNS Diseases)

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 271-273

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Nanotechnology as a Strategy to Improve Treatment of Diabetes)

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 7, 2014-07 ,pp. : 589-589

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Epigenetic Regulation and Human Diseases)

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1595-1597

Bentham Science Publishers

Access to resources Recommend Favorite